BusinessStandard
The drug is designed to treat a type of blood cancer – relapsed or refractory multiple myeloma – in patients who haven’t responded well to other treatments…
Read More
IGI’s new drug ISB 2001 shows promise in treating multiple Myeloma
The drug is designed to treat a type of blood cancer – relapsed or refractory multiple myeloma – in patients who haven’t responded well to other treatments…